Vontobel Holding
BNTX icon

Vontobel Holding’s BioNTech BNTX Stock Holding History

Vontobel Holding’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,000
Closed -$95.2K – 1235
2025
Q4 		$95.2K Buy
+1,000
New +$101K ﹤0.01% 1371

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM

Vontobel Holding's BNTX Position: Q2 2026 in Review

Vontobel Holding reduced its BioNTech (BNTX) stake by 34% in Q2 2026, selling an estimated $3M and leaving 61,238 shares worth $5.7M. The position accounts for 0.02% of the portfolio, ranked #427.

Vontobel Holding first reported a position in BNTX in Q2 2022 and has held it in 17 quarters since. The position peaked at $14.9M in Q1 2023. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • Vontobel Holding held 61,238 shares of BioNTech worth $5.7M as of Q2 2026.
  • Vontobel Holding sold 31,869 BioNTech shares in Q2 2026, an estimated $3M.
  • BioNTech made up 0.02% of Vontobel Holding's portfolio in Q2 2026, its #427 holding.
  • Vontobel Holding first reported a position in BioNTech in Q2 2022 and has held it in 17 quarters since.
  • Vontobel Holding's BioNTech position peaked at $14.9M in Q1 2023.
  • 282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Vontobel Holding's 13F filing for Q2 2026, filed 3 Aug 2026.